Periodic Reporting for period 1 - ReverT (Reversing T cell dysfunction in cancer by multimodal genetic screening)

The key objective of this proposal is to identify new key targets that prevent or revert, in vivo T cell dysfunction in cancer. We had a very successful start of this ERC project: we have already been able to establish a successful foundation in a publication in Cancer Cell...